Table 1.

Efficacy of chemotherapeutic agents. Cell lines were treated with resveratrol (20 μM) prior to the addition of various concentrations of 5-FU (1-100 μM), Mitomycin C (1-10 μM) or gemcitabine (1-100 μM). The IC₅₀ dose was calculated as the dose of the chemotherapeutic agent required to inhibit the proliferation to 50% of the untreated cells in an MTS cell proliferation assay

Chemotherapy	Mz-ChA-1		SG231		HuCCT-1		CCLP-1		H69
	− resv.	+ resv.	− resv.	+ resv.	− resv.	+ resv.	− resv.	+ resv.	− resv.	+ resv.
5-FU	95.01 μM	58.99 μM	61.12 μM	50.72 μM	63.09 μM	43.49 μM	87.48 μM	53.07 μM	206.3 μM	286.3 μM
Mitomycin	9.56. μM	4.39 μM	5.40 μM	1.27 μM	6.12 μM	5.15 μM	7.39 μM	5.95 μM	38.93 μM	21.52 μM
Gemcitabine	101.1 μM	88.18 μM	100.2 μM	60.82 μM	61.0 μM	34.54 μM	95.49 μM	82.45 μM	237.7 μM	200.5 μM